Los Angeles Capital Management’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.98K | Sell |
169
-11,763
| -99% | -$479K | ﹤0.01% | 2082 |
|
|
2025
Q4 | $531K | Sell |
11,932
-5,237
| -31% | -$228K | ﹤0.01% | 863 |
|
|
2025
Q3 | $807K | Sell |
17,169
-5
| -0% | -$259 | ﹤0.01% | 765 |
|
|
2025
Q2 | $894K | Hold |
17,174
| – | – | ﹤0.01% | 673 |
|
|
2025
Q1 | $1.04M | Buy |
17,174
+5,028
| +41% | +$324K | ﹤0.01% | 557 |
|
|
2024
Q4 | $831K | Buy |
12,146
+720
| +6% | +$50.2K | ﹤0.01% | 676 |
|
|
2024
Q3 | $822K | Hold |
11,426
| – | – | ﹤0.01% | 712 |
|
|
2024
Q2 | $792K | Hold |
11,426
| – | – | ﹤0.01% | 732 |
|
|
2024
Q1 | $915K | Hold |
11,426
| – | – | ﹤0.01% | 722 |
|
|
2023
Q4 | $1.25M | Sell |
11,426
-7,696
| -40% | -$796K | ﹤0.01% | 606 |
|
|
2023
Q3 | $1.93M | Sell |
19,122
-1,885
| -9% | -$217K | 0.01% | 460 |
|
|
2023
Q2 | $2.85M | Buy |
+21,007
| New | +$2.56M | 0.01% | 411 |
|
|
2021
Q2 | – | Sell |
-4,460
| Closed | -$582K | – | 1554 |
|
|
2021
Q1 | $582K | Sell |
4,460
-26,608
| -86% | -$3.2M | ﹤0.01% | 1151 |
|
|
2020
Q4 | $3.48M | Sell |
31,068
-290
| -0.9% | -$27.5K | 0.01% | 488 |
|
|
2020
Q3 | $2.47M | Sell |
31,358
-2,232
| -7% | -$182K | 0.01% | 513 |
|
|
2020
Q2 | $2.42M | Sell |
33,590
-4,760
| -12% | -$331K | 0.01% | 565 |
|
|
2020
Q1 | $2.2M | Sell |
38,350
-13,600
| -26% | -$1.25M | 0.01% | 514 |
|
|
2019
Q4 | $5.81M | Sell |
51,950
-8,905
| -15% | -$949K | 0.03% | 386 |
|
|
2019
Q3 | $5.85M | Sell |
60,855
-660
| -1% | -$62K | 0.03% | 384 |
|
|
2019
Q2 | $5.26M | Sell |
61,515
-7,370
| -11% | -$606K | 0.03% | 429 |
|
|
2019
Q1 | $5.73M | Buy |
68,885
+10,150
| +17% | +$737K | 0.03% | 410 |
|
|
2018
Q4 | $3.77M | Buy |
58,735
+5,035
| +9% | +$345K | 0.02% | 418 |
|
|
2018
Q3 | $4.25M | Buy |
53,700
+47,470
| +762% | +$3.67M | 0.02% | 485 |
|
|
2018
Q2 | $456K | Buy |
+6,230
| New | +$424K | ﹤0.01% | 1164 |
|
|
2016
Q4 | – | Sell |
-10,492
| Closed | -$420K | – | 1171 |
|
|
2016
Q3 | $420K | Sell |
10,492
-125
| -1% | -$5.31K | ﹤0.01% | 967 |
|
|
2016
Q2 | $507K | Buy |
+10,617
| New | +$449K | ﹤0.01% | 900 |
|
|
2014
Q2 | – | Sell |
-13,465
| Closed | -$585K | – | 1217 |
|
|
2014
Q1 | $585K | Hold |
13,465
| – | – | 0.01% | 824 |
|
|
2013
Q4 | $572K | Buy |
13,465
+4,740
| +54% | +$180K | 0.01% | 856 |
|
|
2013
Q3 | $296K | Buy |
+8,725
| New | +$285K | ﹤0.01% | 1083 |
|
Other funds holding CNMD
VPM
VCM
CB
Los Angeles Capital Management's CNMD Position: Q1 2026 in Review
Los Angeles Capital Management reduced its CONMED (CNMD) stake by 99% in Q1 2026, selling an estimated $479K and leaving 169 shares worth $5.98K. The position accounts for ﹤0.01% of the portfolio, ranked #2082.
Los Angeles Capital Management first reported a position in CNMD in Q3 2013 and has held it in 29 quarters since. The position peaked at $5.85M in Q3 2019. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.
- Los Angeles Capital Management held 169 shares of CONMED worth $5.98K as of Q1 2026.
- Los Angeles Capital Management sold 11,763 CONMED shares in Q1 2026, an estimated $479K.
- CONMED made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #2082 holding.
- Los Angeles Capital Management first reported a position in CONMED in Q3 2013 and has held it in 29 quarters since.
- Los Angeles Capital Management's CONMED position peaked at $5.85M in Q3 2019.
- 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.
Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.